Orthobiologics Tempe: blood or marrow care for sore joints

What to try when the soreness is mild

Brief rest can settle soreness after you do too much. Gentle movement often keeps a stiff joint from tightening further. Warmth can make the joint easier to bend. After activity, cold may reduce the swelling.

Keep each movement below the point of sharp soreness. You could shorten your walk until the joint calms down. Supportive shoes sometimes ease strain on an aching leg joint. If exercise hurts more, don't repeat that exact motion.

When to have the joint checked

If the ache keeps changing your usual day, it's time to book an exam. Swelling or buckling also means it's worth getting checked. You'll need quicker care if you've had a hard fall. A warm, swollen joint plus a fever needs urgent medical care.

Before the visit, note the day or activity that began the trouble. Name the motions that hurt and those that don't. Include anything that eased the ache for a while. Write each medicine's name, and gather records from earlier visits.

What to ask about treatment choices

Ask the clinician to name what the exam found. Have them explain which choice matches that cause. Cortisone is medicine put at the aching area to calm swelling. It often aims to bring relief sooner.

For blood care, the clinic draws your blood and spins it. Spinning gathers the tiny clotting parts, called platelets, in plasma, the liquid part. The clinic puts this platelet-rich plasma, or PRP, inside the aching joint. You won't always notice a change right away.

At QC Kinetix, medical providers perform the joint exam and may offer these regenerative treatments without surgery. You'll also need the cost, the recovery details, and a date to check any relief. Ask if surgery could still be needed later. You don't need to guess what that question means.

Sources

1. A Bayesian network meta-analysis of 48 Level I-II randomized trials (9,338 knees) with a minimum 6-month follow-up ranked the four commonest intra-articular injections. HA and PRP both significantly improved pain versus placebo; HA, PRP and BMAC all significantly improved function versus placebo. SUCRA rankings were PRP 91.54, BMAC 76.46, HA 53.12, corticosteroid 15.18 and placebo 13.70 - corticosteroid ranked barely above placebo at six months and beyond.

   Jawanda H, et al. — Platelet-Rich Plasma, Bone Marrow Aspirate Concentrate, and Hyaluronic Acid Injections Outperform Corticosteroids in Pain and Function Scores at a Minimum of 6 Months as Intra-Articular Injections for Knee Osteoarthritis: A Systematic Review and Network Meta-analysis.. Arthroscopy, 2024. DOI: 10.1016/j.arthro.2024.01.037.

2. A network meta-analysis restricted to LARGE randomized trials (at least 100 patients per group; 57 RCTs, 22,795 participants, 18 intra-articular interventions) found treatment effects were consistently larger in the 35 high-risk-of-bias trials than in the 22 low/unclear-risk trials. In the main analysis excluding high-risk trials, triamcinolone had the highest probability of exceeding the minimal important difference at weeks 2 and 6; hyaluronic acid had no effect on pain (SMD -0.04, 95% CrI -0.19 to 0.11, 11 trials) but higher odds of dropouts due to adverse events (OR 2.01) and of serious adverse events (OR 1.86). The effects of 16 of the 18 interventions were smaller than the MID and most were consistent with placebo effects.

   Pereira TV, et al. — Effectiveness and safety of intra-articular interventions for knee and hip osteoarthritis based on large randomized trials: A systematic review and network meta-analysis.. Osteoarthritis and Cartilage, 2025. DOI: 10.1016/j.joca.2024.08.014.

3. The largest head-to-head trial of cell-based orthobiologics to date randomised 480 patients with KL II-IV knee OA across four arms: autologous bone marrow aspirate concentrate, autologous adipose stromal vascular fraction, allogeneic umbilical cord tissue-derived MSCs, and a corticosteroid injection control. At 12 months NONE of the three orthobiologic injections was superior to another or to the corticosteroid control on either co-primary endpoint (VAS pain, KOOS pain), and none of the four groups showed a significant change in MRI osteoarthritis score from baseline. No procedure-related serious adverse events were reported.

   Mautner K, et al. — Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial.. Nature Medicine, 2023. DOI: 10.1038/s41591-023-02632-w.

4. The AAOS third-edition clinical practice guideline on non-arthroplasty management of knee osteoarthritis contains 29 recommendations and explicitly highlights intra-articular corticosteroid, hyaluronic acid AND platelet-rich plasma as the areas where better research is still needed - including osteoarthritis characterisation, subgroup and severity stratification, control for bias, and cost-effectiveness analysis.

   Brophy RH, Fillingham YA. — AAOS Clinical Practice Guideline Summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), Third Edition.. Journal of the American Academy of Orthopaedic Surgeons, 2022. DOI: 10.5435/JAAOS-D-21-01233.